TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies ; volume:3 ; number:1 ; day:1 ; month:4 ; year:2015 ; pages:1-8 ; date:12.2015
Acta Neuropathologica Communications ; 3, Heft 1 (1.4.2015), 1-8, 12.2015

Creator: Goossens, Joery
Vanmechelen, Eugeen
Trojanowski, John Q.
Lee, Virginia MY
Broeckhoven, Christine Van
Zee, Julie van der
Engelborghs, Sebastiaan

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40478-015-0195-1

URN: urn:nbn:de:101:1-2021082320264328942354

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Goossens, Joery
Vanmechelen, Eugeen
Trojanowski, John Q.
Lee, Virginia MY
Broeckhoven, Christine Van
Zee, Julie van der
Engelborghs, Sebastiaan
SpringerLink (Online service)

Other Objects (12)

Delusions in frontotemporal lobar degeneration

Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration

In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology

TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration

Frontotemporal Lobar Degeneration: A Clinical Approach

Apraxia phenotypes and frontotemporal lobar degeneration

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

TAF15 amyloid filaments in frontotemporal lobar degeneration

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis

Metabolomic changes associated with frontotemporal lobar degeneration syndromes

Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration

Delusions in frontotemporal lobar degeneration

Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration

In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology

TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration

Frontotemporal Lobar Degeneration: A Clinical Approach

Apraxia phenotypes and frontotemporal lobar degeneration

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

TAF15 amyloid filaments in frontotemporal lobar degeneration

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis

Metabolomic changes associated with frontotemporal lobar degeneration syndromes

Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration

Delusions in frontotemporal lobar degeneration

Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration

In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology

TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration

Frontotemporal Lobar Degeneration: A Clinical Approach

Apraxia phenotypes and frontotemporal lobar degeneration

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

TAF15 amyloid filaments in frontotemporal lobar degeneration

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis

Metabolomic changes associated with frontotemporal lobar degeneration syndromes

Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Delusions in frontotemporal lobar degeneration

Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration

In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology

TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration

Frontotemporal Lobar Degeneration: A Clinical Approach

Apraxia phenotypes and frontotemporal lobar degeneration

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

TAF15 amyloid filaments in frontotemporal lobar degeneration

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis

Metabolomic changes associated with frontotemporal lobar degeneration syndromes

Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration

Delusions in frontotemporal lobar degeneration

Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration

In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology

TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration

Frontotemporal Lobar Degeneration: A Clinical Approach

Apraxia phenotypes and frontotemporal lobar degeneration

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

TAF15 amyloid filaments in frontotemporal lobar degeneration

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis

Metabolomic changes associated with frontotemporal lobar degeneration syndromes

Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration

Delusions in frontotemporal lobar degeneration

Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration

In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology

TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration

Frontotemporal Lobar Degeneration: A Clinical Approach

Apraxia phenotypes and frontotemporal lobar degeneration

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

TAF15 amyloid filaments in frontotemporal lobar degeneration

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis

Metabolomic changes associated with frontotemporal lobar degeneration syndromes

Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration

Related objects

Reset password